The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 29, 2019

Filed:

Mar. 14, 2016
Applicant:

Novimmune SA, Geneva, CH;

Inventors:

Nicolas Fouque, Cernex, FR;

Jean François Depoisier, Mont Saxonnex, FR;

Keith Wilson, Gwent, GB;

Judith Vajda, Leonberg, DE;

Egbert Müller, Darmstadt, DE;

Romain Dabre, Darmstadt, DE;

Assignee:

NovImmune SA, Geneva, CH;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/46 (2006.01); C07K 1/36 (2006.01); C07K 1/16 (2006.01); C07K 1/22 (2006.01); C07K 1/20 (2006.01); C07K 16/00 (2006.01); C07K 16/24 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
C07K 16/468 (2013.01); C07K 1/16 (2013.01); C07K 1/165 (2013.01); C07K 1/20 (2013.01); C07K 1/22 (2013.01); C07K 1/36 (2013.01); C07K 16/00 (2013.01); C07K 16/248 (2013.01); C07K 16/249 (2013.01); C07K 16/2866 (2013.01); C07K 2317/31 (2013.01); C07K 2317/32 (2013.01); C07K 2317/52 (2013.01);
Abstract

The invention relates to the purification of bispecific antibodies carrying a different specificity for each binding site of the immunoglobulin molecule from a mixture of monospecific antibodies. The bispecific antibodies are composed of a single heavy chain and two different light chains, one containing a Kappa constant domain and the other a Lambda constant domain. This invention in particular relates to the isolation of these bispecific antibodies from mixtures that contain monospecific antibodies having two Kappa light chains or portions thereof and monospecific antibodies having two Lambda light chains or portions thereof. The invention also provides the methods of efficiently purifying these bispecific antibodies.


Find Patent Forward Citations

Loading…